On March 16, 2020, the U.S. Meals and Drug Administration launched findings from a sampling project that collected and examined processed avocado and guacamole from November 2017 to September 2019. The project sought to estimate the prevalence of Salmonella spp. and Listeria monocytogenes in processed avocado and guacamole as a part of the FDA’s ongoing effort to proactively guarantee meals security and stop contaminated meals from reaching customers.

In the course of the project the FDA collected and examined a complete of 887 samples of each home and imported processed avocado and guacamole. The company detected Salmonella spp. in two samples, which have been later decided to be distinct samples of the identical model of domestically manufactured guacamole. Neither of those samples had acquired excessive strain processing (HPP) remedy. HPP is a kill step more and more utilized by this business to neutralize dangerous pathogens.

The FDA detected Listeria monocytogenes in 15 samples. Of these 15 samples, eight had not acquired HPP remedy; the company couldn’t decide whether or not the opposite seven samples had acquired HPP remedy. Following complete genome sequencing performed on the pathogens detected, the company decided within the case of every constructive that both there was no linkage to any scientific sicknesses or that the accessible epidemiological data was inconclusive with respect to the meals or different automobile concerned within the sicknesses.

Each time the FDA detected a constructive discovering beneath this project, the company sought to take away all affected product from {the marketplace}. This included refusing import shipments related to constructive product and including two overseas corporations to Import Alert 21-12 which informs FDA subject workers that the company has sufficient proof or different data to permit for Detention With out Bodily Examination of the required merchandise.

Along with affirming that Salmonella spp. and Listeria monocytogenes could also be current in processed avocado and/or guacamole, the project knowledge present that the estimated prevalence of those pathogens within the non-HPP-treated samples was increased than within the HPP-treated samples. These findings seem to align with analysis that signifies HPP is an efficient kill step.

The findings of this project additionally underscore the necessity for processors of processed avocado and guacamole and others within the provide chain to adjust to the company’s Present Good Manufacturing Apply, Hazard Evaluation, and Threat-Based mostly Preventive Controls for Human Meals rule, as relevant. The FDA will proceed to pattern processed avocado and guacamole for pathogens as warranted to guard customers.

For extra data



Please enter your comment!
Please enter your name here